EUVIMEDEUVIMED entdecken
Crossref

HLA‐E high /HLA‐G high /HLA‐II low Human iPSC‐Derived Cardiomyocytes Exhibit Low Immunogenicity for Heart Regeneration

Yi-Hsien Fang, Saprina P H Wang, I-Chuang Liao, Kuen-Jer Tsai, Po-Hsien Huang, Pei-Jung Yang, Chia-Jui Yen, Ping-Yen Liu, Yan-Shen Shan, Yen-Wen Liu iD

Advanced Healthcare Materials · 2023

DOI: 10.1002/adhm.202301186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Yi-Hsien Fang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, 70401, Taiwan. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myocardial Infarction. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, National Science and Technology Council, Taiwan, National Cheng Kung University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although human pluripotent stem cells (hPSCs)‐derived cardiomyocytes (hPSC‐CMs) can remuscularize infarcted hearts and restore post‐infarct cardiac function, post‐transplant rejection resulting from human leukocyte antigen (HLA) mismatching is an enormous obstacle. It is crucial to identify hypoimmunogenic hPSCs for allogeneic cell therapy. This study is conducted to demonstrate the immune privilege of HLA‐E high /HLA‐G high /HLA‐II low human induced pluripotent stem cell (hiPSC)‐derived cardiomyocytes (hiPSC‐CMs). Ischemia‐reperfusion surgery is done to create transmural myocardial infarction in rats. At post‐infarct 4 days, hPSC‐CMs (1.0×10 7 cells per kg), including human embryonic stem cell‐derived cardiomyocytes (hESC‐CMs), HLA‐Elow/HLA‐Glow/HLA‐IIhigh hiPSC‐CMs, and HLA‐E high /HLA‐G high /HLA‐II low hiPSC‐CMs, are injected into the infarcted myocardium. Under the treatment of very low dose cyclosporine A (CsA), only HLA‐E high /HLA‐G high /HLA‐II low hiPSC‐CMs survive in vivo and improved post‐infarct cardiac function with infarct size reduction. HLA‐E high /HLA‐G high /HLA‐II low hiPSC‐CMs activate the SHP‐1 signaling pathway of natural killer (NK) cells and cytotoxic T cells to evade attack by NK cells and cytotoxic T cells. Herein, it is demonstrated that using a clinically relevant CsA dose, HLA‐E high /HLA‐G high /HLA‐II low hiPSC‐CMs repair the infarcted myocardium and restore the post‐infarct heart function. HLA‐E high /HLA‐G high /HLA‐II low hiPSCs are less immunogenic and may serve as platforms for regeneration medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsMyocardial InfarctionHumansRatsAnimalsMyocytes, CardiacHLA-G AntigensRegenerationCell DifferentiationHLA-E Antigens

Stichwörter der Autor:innen

amniotic fluid stem cellscardiac regenerationcardiomyocyteshuman leukocyte antigensimmunogenicitypluripotent stem cells

Substanzen

HLA-G AntigensHLA-E Antigens

Autor:innen und Institutionen

  • Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, 70401, Taiwan.
  • Center of Cell Therapy, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan.
  • Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan.
  • Department of Pathology, Chi-Mei Medical Center, Tainan, 71004, Taiwan.
  • Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan.
  • Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan.

ORCID-Profile: Yen-Wen Liu

Förderung

  • Ministry of Science and Technology, Taiwan
  • National Science and Technology Council, Taiwan
  • National Cheng Kung University Hospital
  • National Science and Technology Council

Zitieren

APA

Fang, Y. H., Wang, S. P. H., Liao, I. C., Tsai, K. J., Huang, P. H., Yang, P. J., Yen, C. J., Liu, P. Y., Shan, Y. S., & Liu, Y. W. (2023). HLA‐E high /HLA‐G high /HLA‐II low Human iPSC‐Derived Cardiomyocytes Exhibit Low Immunogenicity for Heart Regeneration. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202301186

Vancouver

Fang YH, Wang SPH, Liao IC, Tsai KJ, Huang PH, Yang PJ, et al. HLA‐E high /HLA‐G high /HLA‐II low Human iPSC‐Derived Cardiomyocytes Exhibit Low Immunogenicity for Heart Regeneration. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202301186

BibTeX
@article{Fang2023,
  author = {Fang, Yi-Hsien and Wang, Saprina P H and Liao, I-Chuang and Tsai, Kuen-Jer and Huang, Po-Hsien and Yang, Pei-Jung and Yen, Chia-Jui and Liu, Ping-Yen and Shan, Yan-Shen and Liu, Yen-Wen},
  title = {HLA‐E high /HLA‐G high /HLA‐II low Human iPSC‐Derived Cardiomyocytes Exhibit Low Immunogenicity for Heart Regeneration},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  doi = {10.1002/adhm.202301186}
}
Kostenlos starten →